Caris Life Sciences, Inc. (CAI)

Caris Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Dec 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	7,968	-	-	-
Enterprise Value	7,639	-	-	-
Debt / Equity Ratio	0.89	-1.53	-11.04	1.08
Asset Turnover	-	1.09	0.54	-
Inventory Turnover	-	5.24	4.48	-
Quick Ratio	9.09	0.93	1.86	3.29
Current Ratio	9.93	1.30	2.55	3.77
Return on Equity (ROE)	-	-	-293.82%	-
Return on Assets (ROA)	-	-42.48%	-35.34%	-
Return on Capital (ROIC)	-	-93.29%	-55.45%	-
Return on Capital Employed (ROCE)	-8.90%	-144.20%	-100.60%	-54.40%
Buyback Yield / Dilution	-201.21%	-1.59%	-4.73%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q